Browse the Companies or do a name lookup. Theory behind the site Analysis. Contact us.

Zymogenetics Inc  

Company profile

Symbol: ZGEN Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology & Drugs
Market Cap: $623.23 M Data Since: 2003-01-02 Last Close : $10.89 (2008-01-18)
Website: www.zymogenetics.com
Links: [Web Query]    [News Query]

Analysis :    [Random Walk]   [Default Prediction]   [Fundamental Analysis]


Price Prediction

 

Random walk modeling for 2008 (what's this?). Click on the images for the high resolution version.

Initial Value* : $11.67 Historic Volatility : 2.98% Annual Drift : 7%

Predicted price distribution   Predicted high to date and low to date price

* Stock quotes on TextBiz are always adjusted close prices (what's this?).

 

Money Flow Index

 

Money FLow Index for 2008

Money Flow Index   

* To learn more about Money Flow Index (what's this?).

 

Default Prediction for 2007-12-31

 

Default prediction by Z-Score (what's this?).

Z Score :  
-4.048   

Sector         Industry
Zymogenetics Inc Z score histogram (Healthcare sector)   Zymogenetics Inc Z score histogram (Biotechnology & Drugs industry)

View the other companies in the same industry : Biotechnology & Drugs

Alternative Z-Scores designed for non-public companies (i.e. take these with a grain of salt):

For manufacuring companies:
Z' Score :  
-2.9435   

Sector         Industry
Zymogenetics Inc Z' score histogram (Healthcare sector)  Zymogenetics Inc Z' score histogram (Biotechnology & Drugs industry)  

For non-manufacturing companies:
Z'' Score :  
-7.8164   

Sector         Industry
  Zymogenetics Inc Z'' score histogram (Healthcare sector)  Zymogenetics Inc Z score histogram (Biotechnology & Drugs industry)

 

Fundamental Analysis for 2007-

 

Fundamental Analysis measures (what's this?).

Date of financial statements used:  2007-12-31
Book Value : $114.830 M Internal Value : $114.830 M Working Capital : $118.822 M
Debt to Asset Ratio : 0.564 Current Ratio: 0.350 Turnover Ratio: N/A
Net Margins : -1.039 EPS : -2.589 P/E ratio : -4.206
P/B ratio : 5.427 ROE : -1.290 ROA : -0.563